Notice of Termination of PAR-16-399 "Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)"

Notice Number: NOT-CA-17-033

Key Dates
Release Date:   February 28, 2017

Related Announcements
PAR-16-399

Issued by
National Cancer Institute (NCI)

Purpose

This Notice is to inform the research community of the termination of PAR-16-399 "Mentored Patient-Oriented Research Career Development Award to Promote Diversity (K23)", effective immediately.

The following section of PAR-16-399 has been changed.

Part 1. Overview Information, Key Dates

Currently reads:

Expiration Date: January 8, 2018

Modified to read:

Expiration Date: March 1, 2017.

Eligible clinician scientists who wish to apply for a research career development award in cancer-focused patient-oriented research should instead submit applications to:

  • PAR-16-400, The NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08);
  • PAR-16-401, The NCI Mentored Research Scientist Development Award to Promote Diversity (K01); or
  • PAR-17-069, NCI Transition Career Development Award to Promote Diversity (K22)

Inquiries

Please direct all inquiries to:

John O. Ojeifo, M.D., Ph.D., M.B.A.
National Cancer Institute (NCI)
Telephone: 240-276-6186
Email: ojeifojo@mail.nih.gov 

Or

Abigail A. Soyombo, Ph.D., M.B.A.
National Cancer Institute (NCI)
Telephone:240-276-6553
Email: Abigail.soyombo@nih.gov